CPIC Pilot and Feasibility (P&F) Program

The mission of the Congenital and Perinatal Infections Consortium (CPIC) is to eliminate the disease burden associated with rare pediatric viral diseases focusing on congenital cytomegalovirus (CMV) disease, neonatal herpes simplex virus (HSV) infection, and neonatal enterovirus (EV) and human parechovirus (HPeV) sepsis by gathering multi-site data to improve diagnosis, clinical trial readiness, and treatment. The CPIC P&F Program will support research in these areas by providing up to $30,000 each year for projects that contribute to the CPIC mission and utilize the strengths of the Consortium.

Though the specific focus of each Request for Applications (RFA) will be determined on an annual basis by the Executive Committee, all RFAs will stress innovation in our disease areas and extension of research collaborations both within and outside of the CPIC. CPIC pilot projects will advance knowledge and will serve as mentored research opportunities for junior investigators interested in rare diseases. In addition to financial support, pilot recipients will benefit from mentors who serve as part of project management teams designed to ensure research progress and to help them achieve success as independent rare diseases researchers.

The CPIC P&F Program involves a two-phased application process: a Pre-Application and an invited Full Application. Applications undergo peer review in a process similar to that used by the NIH. The 2021 award cycle is closed, but we will announce next year’s RFA in March of 2022. At that time, a copy of the RFA, including instructions for submission, will be linked from this site.